Welcome to our dedicated page for Lumentum Hldgs SEC filings (Ticker: LITE), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Lumentum Holdings Inc.'s SEC filings document operating results, material events, capital-structure actions and governance matters for a photonics and optical communications company. Form 8-K reports furnish quarterly financial results and conference-call materials, as well as securities and charter-related disclosures.
The filings include the completed issuance and sale of Series A Convertible Preferred Stock to NVIDIA and the related certificate of designation, which defines preferred-stock terms and conversion provisions. Proxy materials cover shareholder voting and board governance matters, while exchange-act disclosures identify Lumentum common stock, par value $0.001 per share, trading under LITE on the Nasdaq Global Select Market.
Lumentum Holdings Inc. (LITE) – Form 4 insider transaction
President, Industrial Technology, Vincent Retort reported a disposition (Code “S”) of 22,719 common shares on 29 Jul 2025 at an indicated price of $110 per share, generating proceeds of roughly $2.5 million. The sale was executed under a Rule 10b5-1 trading plan adopted 26 Aug 2024, signalling it was pre-scheduled. Following the sale, Retort’s direct ownership stands at 121,747 shares, implying he reduced his position by about 16 %.
No derivative security activity was reported. The filing does not disclose any company-specific operational or financial updates; its relevance is limited to insider sentiment and potential supply of shares.
Lumentum (NASDAQ:LITE) filed a Form 4 revealing director Alan S. Lowe sold 20,000 common shares on 06/26/2025 at $93.47, generating roughly $1.87 million. The trade, executed under a Rule 10b5-1 plan adopted 11/20/2024, reduced his direct stake by about 8% to 230,471 shares.
No derivative transactions were reported. While pre-scheduled, the sale size exceeds materiality thresholds and may influence investor sentiment.
Lumentum Holdings Director Alan S. Lowe has filed a Form 144 indicating intent to sell 20,000 shares of common stock with an aggregate market value of $1,869,400. The planned sale is scheduled for June 26, 2025, through Morgan Stanley Smith Barney on NASDAQ.
The shares to be sold were acquired through multiple transactions between August 2022 and February 2023, including:
- Restricted Stock grants totaling 5,824 shares
- Performance Share awards totaling 14,176 shares
Notable recent trading activity shows Lowe has sold 30,000 shares in the past three months for total gross proceeds of approximately $2.6 million. The filing indicates Lowe is trading under a 10b5-1 plan adopted on November 20, 2024, and affirms no knowledge of undisclosed material adverse information regarding Lumentum's operations.
Director Alan S. Lowe of Lumentum Holdings has reported a significant insider transaction, selling 20,000 shares of Common Stock at $88.47 per share on June 18, 2025. The transaction was executed under a Rule 10b5-1 trading plan established on November 20, 2024.
Following the sale, Lowe maintains direct ownership of 250,471 shares of Lumentum Holdings. The transaction was reported via Form 4 filing, with attorney Jae Kim signing as the authorized representative on June 20, 2025.
- Transaction value: Approximately $1.77 million
- Trading plan: Executed under pre-established Rule 10b5-1 plan
- Position: Director (Non-executive board member)
- Ownership: Direct beneficial ownership